These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8590808)

  • 21. Increased expression of the NG2 chondroitin-sulfate proteoglycan after brain injury.
    Levine JM
    J Neurosci; 1994 Aug; 14(8):4716-30. PubMed ID: 8046446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple regions of the NG2 proteoglycan inhibit neurite growth and induce growth cone collapse.
    Ughrin YM; Chen ZJ; Levine JM
    J Neurosci; 2003 Jan; 23(1):175-86. PubMed ID: 12514214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The NG2 chondroitin sulfate proteoglycan: a multifunctional proteoglycan associated with immature cells.
    Levine JM; Nishiyama A
    Perspect Dev Neurobiol; 1996; 3(4):245-59. PubMed ID: 9117258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mouse mammary epithelial cells produce basement membrane and cell surface heparan sulfate proteoglycans containing distinct core proteins.
    Jalkanen M; Rapraeger A; Bernfield M
    J Cell Biol; 1988 Mar; 106(3):953-62. PubMed ID: 2964452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Membrane-anchored proteoglycans of mouse macrophages: P388D1 cells express a syndecan-4-like heparan sulfate proteoglycan and a distinct chondroitin sulfate form.
    Yeaman C; Rapraeger AC
    J Cell Physiol; 1993 Nov; 157(2):413-25. PubMed ID: 8227171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteoglycan production by human glomerular visceral epithelial cells and mesangial cells in vitro.
    van Det NF; van den Born J; Tamsma JT; Verhagen NA; van den Heuvel LP; Berden JH; Bruijn JA; Daha MR; van der Woude FJ
    Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):759-68. PubMed ID: 7537959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chondroitin sulfate and cytoplasmic domain-dependent membrane targeting of the NG2 proteoglycan promotes retraction fiber formation and cell polarization.
    Stallcup WB; Dahlin-Huppe K
    J Cell Sci; 2001 Jun; 114(Pt 12):2315-25. PubMed ID: 11493670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor.
    Brand C; Schliemann C; Ring J; Kessler T; Bäumer S; Angenendt L; Mantke V; Ross R; Hintelmann H; Spieker T; Wardelmann E; Mesters RM; Berdel WE; Schwöppe C
    Oncotarget; 2016 Feb; 7(6):6774-89. PubMed ID: 26735180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-localization of NG2 proteoglycan and PDGF alpha-receptor on O2A progenitor cells in the developing rat brain.
    Nishiyama A; Lin XH; Giese N; Heldin CH; Stallcup WB
    J Neurosci Res; 1996 Feb; 43(3):299-314. PubMed ID: 8714519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytoskeletal reorganization induced by engagement of the NG2 proteoglycan leads to cell spreading and migration.
    Fang X; Burg MA; Barritt D; Dahlin-Huppe K; Nishiyama A; Stallcup WB
    Mol Biol Cell; 1999 Oct; 10(10):3373-87. PubMed ID: 10512873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered expression of the MCSP/NG2 chondroitin sulfate proteoglycan in collagen VI deficiency.
    Petrini S; Tessa A; Stallcup WB; Sabatelli P; Pescatori M; Giusti B; Carrozzo R; Verardo M; Bergamin N; Columbaro M; Bernardini C; Merlini L; Pepe G; Bonaldo P; Bertini E
    Mol Cell Neurosci; 2005 Nov; 30(3):408-17. PubMed ID: 16169245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NG2 proteoglycan-binding peptides target tumor neovasculature.
    Burg MA; Pasqualini R; Arap W; Ruoslahti E; Stallcup WB
    Cancer Res; 1999 Jun; 59(12):2869-74. PubMed ID: 10383148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serglycin and betaglycan proteoglycans are expressed in the megakaryocytic cell line CHRF 288-11 and normal human megakaryocytes.
    Schick BP; Jacoby JA
    J Cell Physiol; 1995 Oct; 165(1):96-106. PubMed ID: 7559813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Collagen VI-NG2 axis in human tendon fibroblasts under conditions mimicking injury response.
    Sardone F; Santi S; Tagliavini F; Traina F; Merlini L; Squarzoni S; Cescon M; Wagener R; Maraldi NM; Bonaldo P; Faldini C; Sabatelli P
    Matrix Biol; 2016 Sep; 55():90-105. PubMed ID: 26944560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NG2 proteoglycan increases mesangial cell proliferation and extracellular matrix production.
    Xiong J; Wang Y; Zhu Z; Liu J; Wang Y; Zhang C; Hammes HP; Lang F; Feng Y
    Biochem Biophys Res Commun; 2007 Oct; 361(4):960-7. PubMed ID: 17686464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of NG2-positive oligodendrocyte progenitor cells during post-ischemic reperfusion in the rat brain.
    Tanaka K; Nogawa S; Ito D; Suzuki S; Dembo T; Kosakai A; Fukuuchi Y
    Neuroreport; 2001 Jul; 12(10):2169-74. PubMed ID: 11447328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute brain injuries trigger microglia as an additional source of the proteoglycan NG2.
    Huang W; Bai X; Meyer E; Scheller A
    Acta Neuropathol Commun; 2020 Aug; 8(1):146. PubMed ID: 32843103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of hypoxic-ischemic brain injury in perinatal rats on the abundance and proteolysis of brevican and NG2.
    Aya-ay J; Mayer J; Eakin AK; Muffly BG; Anello M; Sandy JD; Gottschall PE
    Exp Neurol; 2005 May; 193(1):149-62. PubMed ID: 15817274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel laminin-binding form of syndecan-1 (cell surface proteoglycan) produced by syndecan-1 cDNA-transfected NIH-3T3 cells.
    Salmivirta M; Mali M; Heino J; Hermonen J; Jalkanen M
    Exp Cell Res; 1994 Nov; 215(1):180-8. PubMed ID: 7957667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumours.
    Chekenya M; Enger PØ; Thorsen F; Tysnes BB; Al-Sarraj S; Read TA; Furmanek T; Mahesparan R; Levine JM; Butt AM; Pilkington GJ; Bjerkvig R
    Neuropathol Appl Neurobiol; 2002 Oct; 28(5):367-80. PubMed ID: 12366818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.